Insider · CIK 0001132625

VIKING GLOBAL PERFORMANCE LLC

Reports to the SEC for 11 companies · GREENWICH, CT

sec.gov

Transactions

Companies

Filings

CIK

0001132625

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-22	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−111K sh	$9.90	−$1.1M	641,010
2023-06-22	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−5.43M sh	$9.90	−$53.7M	31,409,512
2023-06-22	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−5.24M sh	$9.90	−$51.8M	30,303,871
2023-06-22	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−2.23M sh	$9.90	−$22M	12,884,307
2020-11-11	ADPTAdaptive Biotechnologies CorpS Sale	10% Owner	SSale	−2.5M sh	$49.52	−$124M	30,993,708
2020-01-28	ADPTAdaptive Biotechnologies CorpS Sale	10% Owner	SSale	−4.91M sh	$24.98	−$123M	33,493,708
2019-07-01	ADPTAdaptive Biotechnologies CorpP Purchase	10% Owner	PPurchase	+250K sh	$20.00	+$5M	1,675,000
2019-07-01	ADPTAdaptive Biotechnologies CorpC Conversion	10% Owner	CConversion	+18.9M sh	—	—	20,583,945
2019-07-01	ADPTAdaptive Biotechnologies CorpC Conversion	10% Owner	CConversion	+15.5M sh	—	—	36,108,295
2019-07-01	ADPTAdaptive Biotechnologies CorpC Conversion	10% Owner	CConversion	+2.01M sh	—	—	38,116,035
2019-07-01	ADPTAdaptive Biotechnologies CorpC Conversion	10% Owner	CConversion	+291K sh	—	—	38,406,607
2019-07-01	ADPTAdaptive Biotechnologies Corp · Series D Preferred StockC Conversion	10% Owner	CConversion	−18.9M sh	—	—	0
2019-07-01	ADPTAdaptive Biotechnologies Corp · Series E Preferred StockC Conversion	10% Owner	CConversion	−15.5M sh	—	—	0
2019-07-01	ADPTAdaptive Biotechnologies Corp · Series F Preferred StockC Conversion	10% Owner	CConversion	−2.01M sh	—	—	0
2019-07-01	ADPTAdaptive Biotechnologies Corp · Series F-1 Preferred StockC Conversion	10% Owner	CConversion	−291K sh	—	—	0
2019-06-27	BBIOBridgeBio Pharma, Inc.C Conversion	10% Owner	CConversion	+11.7M sh	—	—	11,736,137
2019-06-27	BBIOBridgeBio Pharma, Inc.C Conversion	10% Owner	CConversion	+10.2M sh	—	—	21,915,091
2019-06-27	BBIOBridgeBio Pharma, Inc.P Purchase	10% Owner	PPurchase	+4.71M sh	$17.00	+$80M	26,620,991
2019-06-27	BBIOBridgeBio Pharma, Inc. · Series C Preferred UnitsC Conversion	10% Owner	CConversion	−51.8M sh	—	—	0
2019-06-27	BBIOBridgeBio Pharma, Inc. · Series D Preferred UnitsC Conversion	10% Owner	CConversion	−50.4M sh	—	—	0
2019-06-19	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+4,957 sh	$8.17	+$40.5K	22,860,013
2019-06-18	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,706 sh	$8.21	+$55.1K	22,855,056
2019-06-17	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,541 sh	$8.53	+$55.8K	22,848,350
2019-06-14	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,144 sh	$7.91	+$56.5K	22,841,809
2019-06-13	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,367 sh	$7.95	+$58.5K	22,834,665
2019-06-12	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$8.30	+$62.2K	22,827,298
2019-06-11	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,189 sh	$8.58	+$61.7K	22,819,798
2019-06-10	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$8.35	+$62.6K	22,812,609
2019-06-07	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,649 sh	$7.96	+$53K	22,805,109
2019-06-06	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,082 sh	$8.00	+$56.6K	22,798,460
2019-06-05	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,540 sh	$8.02	+$52.4K	22,791,378
2019-06-04	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$7.59	+$56.9K	22,784,838
2019-06-04	Myovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+2.42M sh	$8.25	+$20M	40,765,599
2019-06-03	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,424 sh	$7.71	+$41.8K	22,777,338
2019-05-31	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,071 sh	$7.70	+$39K	22,771,914
2019-05-30	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,951 sh	$7.97	+$55.4K	22,766,543
2019-05-30	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+300 sh	$8.91	+$2,671.98	22,766,843
2019-05-29	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,882 sh	$7.55	+$52K	22,759,592
2019-05-28	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+3,807 sh	$7.68	+$29.2K	22,752,710
2019-05-24	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+3,796 sh	$7.70	+$29.2K	22,748,903
2019-05-23	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+4,802 sh	$7.76	+$37.3K	22,745,107
2019-05-22	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,033 sh	$8.06	+$40.6K	22,740,305
2019-05-21	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+9,995 sh	$8.52	+$85.1K	22,735,272
2019-05-20	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+8,285 sh	$7.98	+$66.1K	—
2019-05-20	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+1,715 sh	$8.39	+$14.4K	—
2019-05-17	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,200 sh	$7.36	+$45.6K	—
2019-05-16	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,408 sh	$6.79	+$36.7K	22,709,077
2019-03-18	Sio Gene Therapies Inc.P Purchase	Former 10% Owner	PPurchase	+6.67M sh	$1.50	+$10M	105,952,381
2018-12-18	Sio Gene Therapies Inc.P Purchase	Former 10% Owner	PPurchase	+10M sh	$1.00	+$10M	99,285,714
2018-10-01	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+2.68M sh	$14.00	+$37.5M	22,703,669

Recent filings

Accepted (ET)
Jun 264
VIKING GLOBAL PERFORMANCE LLC0001140361-23-031456
SEC(opens sec.gov)
Nov 134
VIKING GLOBAL PERFORMANCE LLC0001387131-20-009936
SEC(opens sec.gov)
Jan 304
VIKING GLOBAL PERFORMANCE LLC0000903423-20-000011
SEC(opens sec.gov)
Jul 24
VIKING GLOBAL PERFORMANCE LLC0000903423-19-000273
SEC(opens sec.gov)
Jun 284
VIKING GLOBAL PERFORMANCE LLC0000903423-19-000266
SEC(opens sec.gov)

Companies

Address

55 RAILROAD AVENUE

GREENWICH, CT, 06830